2m 2m 2m 2m 2m 2m 2m
Exozymes (EXOZ)
NASDAQ
$9.66+$0.16 (+1.68%)
Price as of Jun 03, 2026 4:10 PM EDT- $83.5MMarket Cap
- -32.96%1-Year Change
- BiotechnologyIndustry
Exozymes (EXOZ)
$9.66+$0.16 (+1.68%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 44
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$9.38
$9.71
$9.50
1-Year Range
$7.09
$16.50
$9.50
Latest Close$9.50
Change
-$0.17 (-1.79%)
Volume8,060
Market Cap$83.5M
Shares Outstanding8.5M
P/E (TTM)-36.18
Diluted EPS (TTM)-$0.27
Enterprise Value$82.0M
Information as of 06/02/2026
Company Profile
EXOZYMES INC
https://www.exozymes.com$83.5M
Market Cap
-$2.3M
Net Income
Sector: Healthcare
Industry: Biotechnology
750 Royal Oaks Drive, Monrovia, CA, United States, 91016
626 415 1488eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.
Key Executives
- Michael Heltzen
- Damien A. Perriman
- Tyler Korman
- Fouad Nawaz
- Paul Opgenorth
Current Ownership Distribution
- Other6.9M (80.80%)
- Insiders1.5M (18.11%)
- Institutions62,895 (0.74%)
- Mutual Funds29,029 (0.34%)